Company intelligence / Profile preview

All G Foods

Waterloo, Sydney, New South Wales, Australiaallg.com ↗

Ownership: Private
Development stage: Preclinical

Overview

All G Foods has made a significant breakthrough in understanding the structure of the casein micelle, positioning them as a global leader in this field. They are currently working with regulators to gain pre-market approvals.

Therapeutic areas: Metabolic Disorders
Modalities: Precision fermentation-derived proteins
Industry: Non-Drug Biotech

Drug pipeline

2 assets

lactoferrin

Pre-clinical

Indications: Nutrition

1 more asset in the full pipeline.

Request access →

Partnerships

University of Sydneymanufacturers globally

Beyond the preview

Go deeper on All G Foods.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on All G Foods.

Explore the full profile